Literature DB >> 16269534

Constraining the expression of nicotinic acetylcholine receptors by using pentameric constructs.

Paul J Groot-Kormelink1, Steven Broadbent, Marco Beato, Lucia G Sivilotti.   

Abstract

Much of our understanding of ligand-gated ion channels comes from heterologous expression studies. However, this technique cannot produce receptors with a predetermined subunit composition for channels formed by several different subunits and cannot insert a single mutation copy if the subunit of interest is present in several copies in the channel. Here, we describe a novel approach that overcomes these problems by expressing pentameric constructs, in which the code of the five subunits is linked (i.e., beta4_beta4_alpha3_beta4_alpha3). This is the first time that a concatemer of the complete pentameric receptor has been expressed for channels in the cysteine-loop superfamily. The presence of the linker did not change the agonist or antagonist sensitivity of alpha3beta4 nicotinic receptors. We show evidence that the expressed receptors were made up of alpha3 and beta4 subunits in one pentameric fusion protein as designed in the construct. This approach can be applied to any nicotinic superfamily receptor to produce channels with a defined subunit arrangement and to introduce specific mutations at any desired location of the pentameric fusion protein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16269534     DOI: 10.1124/mol.105.019356

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  19 in total

1.  Function of human α3β4α5 nicotinic acetylcholine receptors is reduced by the α5(D398N) variant.

Authors:  Andrew A George; Linda M Lucero; M Imad Damaj; Ronald J Lukas; Xiangning Chen; Paul Whiteaker
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  Alpha-conotoxin AuIB isomers exhibit distinct inhibitory mechanisms and differential sensitivity to stoichiometry of alpha3beta4 nicotinic acetylcholine receptors.

Authors:  Anton A Grishin; Ching-I A Wang; Markus Muttenthaler; Paul F Alewood; Richard J Lewis; David J Adams
Journal:  J Biol Chem       Date:  2010-05-13       Impact factor: 5.157

3.  Expression of functional human α6β2β3* acetylcholine receptors in Xenopus laevis oocytes achieved through subunit chimeras and concatamers.

Authors:  Alexandre Kuryatov; Jon Lindstrom
Journal:  Mol Pharmacol       Date:  2010-10-05       Impact factor: 4.436

4.  A tale of ligands big and small: an update on how pentameric ligand-gated ion channels interact with agonists and proteins.

Authors:  Stephan A Pless; Lucia G Sivilotti
Journal:  Curr Opin Physiol       Date:  2019-06-12

Review 5.  Determination of the architecture of ionotropic receptors using AFM imaging.

Authors:  Nelson P Barrera; Robert M Henderson; J Michael Edwardson
Journal:  Pflugers Arch       Date:  2007-11-17       Impact factor: 3.657

Review 6.  Tandem couture: Cys-loop receptor concatamer insights and caveats.

Authors:  Spencer S Ericksen; Andrew J Boileau
Journal:  Mol Neurobiol       Date:  2007-02       Impact factor: 5.590

7.  Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression.

Authors:  A-L Carbone; M Moroni; P-J Groot-Kormelink; I Bermudez
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

Review 8.  What single-channel analysis tells us of the activation mechanism of ligand-gated channels: the case of the glycine receptor.

Authors:  Lucia G Sivilotti
Journal:  J Physiol       Date:  2009-09-21       Impact factor: 5.182

Review 9.  Using concatenated subunits to investigate the functional consequences of heterotetrameric inositol 1,4,5-trisphosphate receptors.

Authors:  Rahul Chandrasekhar; Kamil J Alzayady; David I Yule
Journal:  Biochem Soc Trans       Date:  2015-06       Impact factor: 5.407

10.  Heterologous expression of concatenated nicotinic ACh receptors: Pros and cons of subunit concatenation and recommendations for construct designs.

Authors:  Vivian Wan Yu Liao; Ali Saad Kusay; Thomas Balle; Philip Kiaer Ahring
Journal:  Br J Pharmacol       Date:  2020-08-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.